Global Rabies Treatment Market Research Report 2019
Table of Contents
Executive Summary
1 Rabies Treatment Market Overview
- 1.1 Product Overview and Scope of Rabies Treatment
- 1.2 Rabies Treatment Segment by Type
- 1.2.1 Global Rabies Treatment Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Cell culture vaccines (CCVs)
- 1.2.3 Rabies immunoglobulin (RIGs)
- 1.2.4 Nerve tissue vaccines (NTVs)
- 1.3 Rabies Treatment Segment by Application
- 1.3.1 Rabies Treatment Consumption Comparison by Application (2014-2025)
- 1.3.2 Pre-exposure prophylaxis
- 1.3.3 Post-exposure prophylaxis
- 1.3 Global Rabies Treatment Market by Region
- 1.3.1 Global Rabies Treatment Market Size Region
- 1.3.2 North America Status and Prospect (2014-2025)
- 1.3.3 Europe Status and Prospect (2014-2025)
- 1.3.4 China Status and Prospect (2014-2025)
- 1.3.5 Japan Status and Prospect (2014-2025)
- 1.3.6 Southeast Asia Status and Prospect (2014-2025)
- 1.3.7 India Status and Prospect (2014-2025)
- 1.4 Global Rabies Treatment Market Size
- 1.4.1 Global Rabies Treatment Revenue (2014-2025)
- 1.4.2 Global Rabies Treatment Production (2014-2025)
2 Global Rabies Treatment Market Competition by Manufacturers
- 2.1 Global Rabies Treatment Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Rabies Treatment Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Rabies Treatment Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Rabies Treatment Production Sites, Area Served, Product Types
- 2.5 Rabies Treatment Market Competitive Situation and Trends
- 2.5.1 Rabies Treatment Market Concentration Rate
- 2.5.2 Rabies Treatment Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Rabies Treatment Production Market Share by Regions
- 3.1 Global Rabies Treatment Production Market Share by Regions
- 3.2 Global Rabies Treatment Revenue Market Share by Regions (2014-2019)
- 3.3 Global Rabies Treatment Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Rabies Treatment Production
- 3.4.1 North America Rabies Treatment Production Growth Rate (2014-2019)
- 3.4.2 North America Rabies Treatment Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Rabies Treatment Production
- 3.5.1 Europe Rabies Treatment Production Growth Rate (2014-2019)
- 3.5.2 Europe Rabies Treatment Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Rabies Treatment Production (2014-2019)
- 3.6.1 China Rabies Treatment Production Growth Rate (2014-2019)
- 3.6.2 China Rabies Treatment Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Rabies Treatment Production (2014-2019)
- 3.7.1 Japan Rabies Treatment Production Growth Rate (2014-2019)
- 3.7.2 Japan Rabies Treatment Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Rabies Treatment Consumption by Regions
- 4.1 Global Rabies Treatment Consumption by Regions
- 4.2 North America Rabies Treatment Consumption (2014-2019)
- 4.3 Europe Rabies Treatment Consumption (2014-2019)
- 4.4 China Rabies Treatment Consumption (2014-2019)
- 4.5 Japan Rabies Treatment Consumption (2014-2019)
5 Global Rabies Treatment Production, Revenue, Price Trend by Type
- 5.1 Global Rabies Treatment Production Market Share by Type (2014-2019)
- 5.2 Global Rabies Treatment Revenue Market Share by Type (2014-2019)
- 5.3 Global Rabies Treatment Price by Type (2014-2019)
- 5.4 Global Rabies Treatment Production Growth by Type (2014-2019)
6 Global Rabies Treatment Market Analysis by Applications
- 6.1 Global Rabies Treatment Consumption Market Share by Application (2014-2019)
- 6.2 Global Rabies Treatment Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Rabies Treatment Business
- 7.1 Cadila Healthcare
- 7.1.1 Cadila Healthcare Rabies Treatment Production Sites and Area Served
- 7.1.2 Rabies Treatment Product Introduction, Application and Specification
- 7.1.3 Cadila Healthcare Rabies Treatment Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 GlaxoSmithKline
- 7.2.1 GlaxoSmithKline Rabies Treatment Production Sites and Area Served
- 7.2.2 Rabies Treatment Product Introduction, Application and Specification
- 7.2.3 GlaxoSmithKline Rabies Treatment Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Merial
- 7.3.1 Merial Rabies Treatment Production Sites and Area Served
- 7.3.2 Rabies Treatment Product Introduction, Application and Specification
- 7.3.3 Merial Rabies Treatment Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Sanofi
- 7.4.1 Sanofi Rabies Treatment Production Sites and Area Served
- 7.4.2 Rabies Treatment Product Introduction, Application and Specification
- 7.4.3 Sanofi Rabies Treatment Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Merck
- 7.5.1 Merck Rabies Treatment Production Sites and Area Served
- 7.5.2 Rabies Treatment Product Introduction, Application and Specification
- 7.5.3 Merck Rabies Treatment Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Pfizer
- 7.6.1 Pfizer Rabies Treatment Production Sites and Area Served
- 7.6.2 Rabies Treatment Product Introduction, Application and Specification
- 7.6.3 Pfizer Rabies Treatment Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Bayer
- 7.7.1 Bayer Rabies Treatment Production Sites and Area Served
- 7.7.2 Rabies Treatment Product Introduction, Application and Specification
- 7.7.3 Bayer Rabies Treatment Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 AstraZeneca
- 7.8.1 AstraZeneca Rabies Treatment Production Sites and Area Served
- 7.8.2 Rabies Treatment Product Introduction, Application and Specification
- 7.8.3 AstraZeneca Rabies Treatment Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Amneal Pharmaceuticals
- 7.9.1 Amneal Pharmaceuticals Rabies Treatment Production Sites and Area Served
- 7.9.2 Rabies Treatment Product Introduction, Application and Specification
- 7.9.3 Amneal Pharmaceuticals Rabies Treatment Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Anergis
- 7.10.1 Anergis Rabies Treatment Production Sites and Area Served
- 7.10.2 Rabies Treatment Product Introduction, Application and Specification
- 7.10.3 Anergis Rabies Treatment Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
8 Rabies Treatment Manufacturing Cost Analysis
- 8.1 Rabies Treatment Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Rabies Treatment
- 8.4 Rabies Treatment Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Rabies Treatment Distributors List
- 9.3 Rabies Treatment Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Rabies Treatment Market Forecast
- 11.1 Global Rabies Treatment Production, Revenue Forecast
- 11.1.1 Global Rabies Treatment Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Rabies Treatment Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Rabies Treatment Price and Trend Forecast (2019-2025)
- 11.2 Global Rabies Treatment Production Forecast by Regions (2019-2025)
- 11.2.1 North America Rabies Treatment Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Rabies Treatment Production, Revenue Forecast (2019-2025)
- 11.2.3 China Rabies Treatment Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Rabies Treatment Production, Revenue Forecast (2019-2025)
- 11.3 Global Rabies Treatment Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Rabies Treatment Consumption Forecast (2019-2025)
- 11.3.2 Europe Rabies Treatment Consumption Forecast (2019-2025)
- 11.3.3 China Rabies Treatment Consumption Forecast (2019-2025)
- 11.3.4 Japan Rabies Treatment Consumption Forecast (2019-2025)
- 11.4 Global Rabies Treatment Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Rabies Treatment Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
The global Rabies Treatment market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Rabies Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rabies Treatment market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Cadila Healthcare
GlaxoSmithKline
Merial
Sanofi
Merck
Pfizer
Bayer
AstraZeneca
Amneal Pharmaceuticals
Anergis
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Cell culture vaccines (CCVs)
Rabies immunoglobulin (RIGs)
Nerve tissue vaccines (NTVs)
Segment by Application
Pre-exposure prophylaxis
Post-exposure prophylaxis